MULTI-CENTER AND PROSPECTIVE COHORT STUDY OF 599 JAPANESE PATIENTS WITH HCV GENOTYPE 1 INFECTION REVEALS SUSTAINED VIROLOGICAL RESPONSE BY LEDIPASVIR/SOFOSBUVIR REDUCES THE INCIDENCE OF HEPATOCELLULAR CARCINOMA AS SAME AS PEG-INTERFERON PLUS RIBAVIRIN